Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kendall

Showing results (21-30 of 810) with videos related to

Pageof 81
Sort By:
Basic Research in Cardiology|December 2, 1998
Therapeutic advantages of AT1 blockers in hypertensionM J Kendall
Journal of Clinical Pharmacy and Therapeutics|December 1, 1987
Therapeutic progress--review. XXIX. Is there a role for low-dose angiotensin converting enzyme inhibitors in the treatment of mild to moderate hypertension?M J Kendall
Journal of Clinical Pharmacy and Therapeutics|June 1, 1987
Dementia--further progressM J Kendall
Journal of Clinical Pharmacy and Therapeutics|June 1, 1989
Metoprolol-controlled release, zero order kineticsM J Kendall
Heart (British Cardiac Society)|November 27, 1999
Possible mechanisms of action in the positive effect of beta blockers in heart failureM J Kendall
Journal of Clinical Pharmacy and Therapeutics|June 1, 1990
Long-term therapeutic efficacy with once-daily isosorbide-5-mononitrate (Imdur)M J Kendall
British Medical Journal|March 29, 1975
Letter: Medical management of transient ischaemic attacksM J Kendall
Journal of the Royal College of Physicians of London|January 1, 1981
Are selective beta-adrenoceptor blocking drugs an advantage?M J Kendall
The American Journal of Cardiology|May 15, 1987
Impact of beta 1 selectivity and intrinsic sympathomimetic activity on potential unwanted noncardiovascular effects of beta blockersM J Kendall
British Medical Journal|March 4, 1972
Spontaneous fracture of pelvis in rheumatoid arthritisM J Kendall
Pageof 81

Showing results (21-30 of 810) with videos related to

Sort By:
Pageof 81
Basic Research in Cardiology|December 2, 1998
Therapeutic advantages of AT1 blockers in hypertensionM J Kendall
Journal of Clinical Pharmacy and Therapeutics|December 1, 1987
Therapeutic progress--review. XXIX. Is there a role for low-dose angiotensin converting enzyme inhibitors in the treatment of mild to moderate hypertension?M J Kendall
Journal of Clinical Pharmacy and Therapeutics|June 1, 1987
Dementia--further progressM J Kendall
Journal of Clinical Pharmacy and Therapeutics|June 1, 1989
Metoprolol-controlled release, zero order kineticsM J Kendall
Heart (British Cardiac Society)|November 27, 1999
Possible mechanisms of action in the positive effect of beta blockers in heart failureM J Kendall
Journal of Clinical Pharmacy and Therapeutics|June 1, 1990
Long-term therapeutic efficacy with once-daily isosorbide-5-mononitrate (Imdur)M J Kendall
British Medical Journal|March 29, 1975
Letter: Medical management of transient ischaemic attacksM J Kendall
Journal of the Royal College of Physicians of London|January 1, 1981
Are selective beta-adrenoceptor blocking drugs an advantage?M J Kendall
The American Journal of Cardiology|May 15, 1987
Impact of beta 1 selectivity and intrinsic sympathomimetic activity on potential unwanted noncardiovascular effects of beta blockersM J Kendall
British Medical Journal|March 4, 1972
Spontaneous fracture of pelvis in rheumatoid arthritisM J Kendall
Pageof 81